Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (31-40 of 357) with videos related to

Pageof 36
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|December 17, 2008
SRC as a therapeutic target in breast cancerLiam Morgan, Robert I Nicholson, Stephen Hiscox
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|March 29, 2001
Electron spin relaxation time measurements using radiofrequency longitudinally detected ESR and application in oximetryI Panagiotelis, I Nicholson, J M Hutchison
European Journal of Cancer|April 1, 1973
Lysosomal enzymes in 7, 12-dimethylbenz(a)anthracene-induced mammary carcinomas after ovariectomyR I Nicholson, I Bagnall, M Davies
The Journal of Endocrinology|April 1, 1977
Early increases in ribonucleic acid polymerase activities of dimethylbenzanthracene-induced mammary tumour nuclei in response to oestradiol-17beta and tamoxifenR I Nicholson, P Davies, K Griffiths
European Journal of Cancer|March 29, 1977
Effects of oestradiol-17beta and tamoxifen on nuclear oestradiol-17beta receptors in DMBA-induced rat mammary tumoursR I Nicholson, P Davies, K Griffiths
Breast Cancer Research : BCR|June 10, 2003
Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitizationJulia M W Gee, Robert I Nicholson
European Journal of Cancer|April 1, 1978
Interaction of androgens with oestradiol-17beta receptor proteins in DMBA-induced mammary tumours--a possible oncolytic mechanismR I Nicholson, P Davies, K Griffiths
Expert Opinion on Therapeutic Targets|March 11, 2011
Therapeutic targeting of tumor-stroma interactionsStephen Hiscox, Peter Barrett-Lee, Robert I Nicholson
Trends in Endocrinology and Metabolism: TEM|November 16, 2004
Zinc transporter LIV-1: a link between cellular development and cancer progressionKathryn M Taylor, S Hiscox, R I Nicholson
Dermatology (Basel, Switzerland)|January 1, 1993
HLA DR4 is associated with the development of multiple basal cell carcinomas and malignant melanomaD Czarnecki, I Nicholson, B Tait, et al.
Pageof 36

Showing results (31-40 of 357) with videos related to

Sort By:
Pageof 36
Endocrine, Metabolic & Immune Disorders Drug Targets|December 17, 2008
SRC as a therapeutic target in breast cancerLiam Morgan, Robert I Nicholson, Stephen Hiscox
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|March 29, 2001
Electron spin relaxation time measurements using radiofrequency longitudinally detected ESR and application in oximetryI Panagiotelis, I Nicholson, J M Hutchison
European Journal of Cancer|April 1, 1973
Lysosomal enzymes in 7, 12-dimethylbenz(a)anthracene-induced mammary carcinomas after ovariectomyR I Nicholson, I Bagnall, M Davies
The Journal of Endocrinology|April 1, 1977
Early increases in ribonucleic acid polymerase activities of dimethylbenzanthracene-induced mammary tumour nuclei in response to oestradiol-17beta and tamoxifenR I Nicholson, P Davies, K Griffiths
European Journal of Cancer|March 29, 1977
Effects of oestradiol-17beta and tamoxifen on nuclear oestradiol-17beta receptors in DMBA-induced rat mammary tumoursR I Nicholson, P Davies, K Griffiths
Breast Cancer Research : BCR|June 10, 2003
Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitizationJulia M W Gee, Robert I Nicholson
European Journal of Cancer|April 1, 1978
Interaction of androgens with oestradiol-17beta receptor proteins in DMBA-induced mammary tumours--a possible oncolytic mechanismR I Nicholson, P Davies, K Griffiths
Expert Opinion on Therapeutic Targets|March 11, 2011
Therapeutic targeting of tumor-stroma interactionsStephen Hiscox, Peter Barrett-Lee, Robert I Nicholson
Trends in Endocrinology and Metabolism: TEM|November 16, 2004
Zinc transporter LIV-1: a link between cellular development and cancer progressionKathryn M Taylor, S Hiscox, R I Nicholson
Dermatology (Basel, Switzerland)|January 1, 1993
HLA DR4 is associated with the development of multiple basal cell carcinomas and malignant melanomaD Czarnecki, I Nicholson, B Tait, et al.
Pageof 36